|
Chapter 4. Tissue Repair: Cellular Growth,
Fibrosis, and Wound Healing
ÇнÀ¸ñÀû ¼¼Æ÷ÀÇ ½ÅÈ£Àü´Þü°è¸¦ ÀÌÇØÇÔÀ¸·Î½á ¼¼Æ÷ÀÇ È°µ¿ÀÌ ¾î¶»°Ô Á¶ÀýµÇ´ÂÁö¸¦ ¾Ë°í,
½ÅÈ£Àü´Þü°è°¡ Àß ¸ø µÇ¾úÀ» ¶§ ¾î¶² ÀÏÀÌ ¹ú¾îÁú ¼ö Àִ°¡¸¦ »ý°¢Çϸç, Ä¡À¯¿Í ¼öº¹°úÁ¤À»
ÀÌÇØÇÑ´Ù.
CONTROL OF NORMAL CELL GROWTH
Cell Cycle and Proliferative Potential
- Labile Cells
: Continuously dividing cells |
ü¼¼Æ÷¸¦ Àç»ý´É·Â¿¡
µû¶ó ºÐ·ùÇϰí, ±×
Ư¼ºÀ» ¼³¸íÇÑ´Ù. (A) |
: Surface epithelia; Squamous, columnar,
transitional
Hematopoietic, lymphoid, splenic tissue |
|
- Stable cells
: Quiescent cells, dividing by stimulation
: Parenchymal cells of glandular organs;
Liver, kidney, pancreas
Mesenchymal cells;
Fibroblasts, endothelial cells, smooth muscle cells,
chondroblasts, osteoblasts,
: The underlying framework of the parenchymal
cells, mainly the basement membrane, is
necessary for organized regeneration |
regeneration re- +
L. generare to
produce, bring to
life |
- Permanent cells
: Nondividing cells in postnatal life
: Nerve cells
Skeletal and cardiac muscle cells, practically

Cell populations and cell cycle phases.
Constantly dividing labile cells continuously cycle
from one mitosis to the next. Nondividing permanent
cells have exited the cycle and are destined to die
without further division. Quiescent stable cells in
G0 are neither cycling nor dying and can be induced
to re-enter the cell cycle by an appropriate
stimulus. |
Molecular Events in Cell Growth - Biosignaling

|
Cell Signaling
Plasma membrane
receptorÀÇ Á¾·ù¸¦
¿°ÅÇÑ´Ù. (A)
|
Plasma membrane receptors
0. Ligand-gated ion channels
1. Receptor enzymes
(1) TK receptors (Receptors with intrinsic kinase activity)
(2) Serine-threonine kinase receptor
(3) Guanylyl cyclase receptors
2. Receptor non-enzymes (Cytokine receptor superfamily)
(1) JAK/STAT system
3. G protein-linked receptors (Seven-spanning receptors,
Serpentine receptors)
<Signal Transduction Pathway>
I. Ligand-receptor binding, membranous
II. Activation of receptors
III. Signal transduction and second messengers
1. Receptor enzymes
|
signal transduction
pathwayÀÇ °úÁ¤À»
¼³¸íÇÑ´Ù. (A)
G proteins = Guanine
nucleotide-binding)
proteins) with
intrinsic GTPase
activity
- Monomeric G
proteins (ras)
- Heterotrimeric G
proteins (G¥á¥â¥ã) |
(1) TK receptors (Receptors with intrinsic kinase activity) -
InsulinR, EGFR(c-erb B1), PDGFR, FGFR, VEGFR,AngiopoietinR
(a) MAP kinase pathway (ras pathway)
(b) PI-3-kinase pathway
(Phosphoinositide-3-kinase pathway)
(c) IP3 pathway (Phospholipase C (PLC¥ã) pathway)
: PLC¥ã = IP3 - Ca++ - Ca++-binding proteins¡è
= DAG - PKC¡è
(Tumor promoter: Phorbol esters)
(d) src family pathway (with tyrosine kinase activity)
(2) Serine-threonine kinase receptor
(a) TGF¥â receptor
(3) Guanylyl cyclase receptors
(a) ANP receptor, guanylin receptor
(b) NO receptor
2. Receptor non-enzymes (Cytokine receptor superfamily)
(1) JAK/STAT system: Cytokine receptors, leptin receptor
3. G protein-linked receptors (Seven-spanning receptors,
Serpentine receptors)
: Heterotrimeric G proteins (G¥á¥â¥ã)
(1) cAMP pathway
- ¥â-Adrenergic R., glucagon R., chemokine Rs.
: Gs - Adenylate cyclase - cAMP - PKA¡è
- Somatostatin R.
: Gi - Adenylate cyclase¡é - cAMP¡é - PKA¡é
- Gustatory R.
: Ggust - Adenylate cyclase - cAMP - PKA¡è - PK+¡é
(gustducin) (depolarization)
- Olfactory R.
: Golf - Adenylate cyclase - cAMP - PCa++, Na+¡è
(depolarization)
cGMP pathway
- Photoreceptor (rhodopsin)
: Transducin - Phosphodiesterase-cGMP¡é-PCa++, Na+¡é
(hyperpolarization)
(2) IP3 pathway (Phospholipase C (PLC¥â) pathway)
- Olfactory R.
: Golf - PLC¥â - IP3 - PCa++¡è (depolarization)
- Chemokine Rs.,
Acetylcholine [muscarinic M1] R.,
¥á1-adrenergic agonist R.
: Gq - PLC¥â = IP3 - Ca++ - Ca++-binding proteins¡è
= DAG - PKC¡è
(Tumor promoter: Phorbol esters)
IV. Transcription factors
1. Early response genes
: c-fos, c-jun, c-myc
2. Late response genes
*. Phosphatases
: Phosphatase inhibitor - Tumor promoter: Okadoic acid
Signaling from activated tyrosine kinase receptors

(a) MAP-kinase pathway (ras pathway)
Binding of a growth factor causes the receptor
to dimerize and cross-phosphorylate tyrosine
residues. Binding of adapter (or bridging) proteins
(e.g. GRB2 and SOS) couple the receptor with inactive
Ras. Cycling of Ras between its inactive and active
forms is regulated by GAP. Activated Ras interacts
with and activates Raf-1. This kinase then
phosphorylates a component of the MAPK signaling
pathway, MEK, which then phosphorylates MAPK (ERK).
Activated MAPK phosphorylates other cytoplasmic
proteins and nuclear transcription factors generating
cellular responses. The phosphorylated tyrosine
kinase receptor can also bind other components, such
as PI-3 kinase, which activates distinct signaling
systems.
(b) PI-3-kinase pathway
(Phosphoinositide-3-kinase pathway)
Ligand - Tyrosine kinase receptor ¡æ
PI-3-K (PI3-kinase = Phosphoinositide-3-kinase) ¡æ
PIP2 (phosphatidyl inositol bisphosphate) ¡æ
PIP3 (phosphatidyl inositol trisphosphate) ¡æ
PKB (protein kinase B) ¡æ
Phosphorylation of target proteins
(c) IP3 pathway
(Phospholipase C (PLC¥ã) pathway)
Vide infra (Phospholipase C (PLC¥â) pathway)
(d) src family pathway,
with tyrosine kinase activity
|
ras pathway¸¦ ±×¸²À¸·Î
¼³¸íÇÑ´Ù. (A)
GRB2 = Growth factor
Receptor Binding
protein 2 with SH2
domain (Src Homology
domain 2)
(Src = encoded by src
gene of avian sarcoma
virus)
SOS = son of
sevenless = GNRP =
Guanine nucleotide
releasing protein
ras = rat sarcoma
virus
GAPs = GTPase
activating proteins
Raf-1 = Ras-activated
factor 1
MEK = MAPK/ERK
activating kinase
MAPK =
Mitogen-Activated
Protein Kinase = ERK
(Extracellular
signal-Regulated
Kinase)
inositol G. is,
(gen,) inos fiber,
muscle finer, sinew +
ISV -ite + -ol
PI-3-kinase pathway¸¦
¼³¸íÇÑ´Ù. (A)
PI-3-kinase =
phospho-
inositide-3-kinase
PIP2 = phosphatidyl
inositol
4,5-bisphosphate
PIP3 = phosphatidyl
inositol
3,4,5-trisphosphate
PLC¥ã
Phospholipase C¥ã,
with SH2 domain,
activated by
tyrosine kinase
receptors
DAG = 1,2-diacyl
glycerol
IP3 = inositol
1,4,5-trisphosphate
PKC Ca++-dependent
protein kinase
|
* SOS (son of sevenless) = GNRP (Guanine nucleotide
releasing protein).
The eye of Drosphila is composed of about 800
identical units, each having a separate lens that
focuses light onto eight photoreceptor cells at its
base. R7 is the last photoreceptor cell to develop,
required for the detection of UV light. A mutant fly
with R7 defect is called sevenless (sev), and the gene
sev. The sev gene is a receptor tyrosine kinase and
requires a second gene, son-of sevenless (sos), to
activate Ras. The sos gene encodes GNRP.
|
SEM of a compound eye
of Drosophila.
 |
Signaling from activated receptor non-enzymes

JAK/STAT system by which the leptin signal is
transduced in the hypothalamus. Leptin binding induces
dimerization of the leptin receptor, followed by
phosphorylation of Tyr residues of the receptor,
catalyzed by JAK. STATs that bind to the
phosphorylated leptin ceceptor are then phosphorylated
on Tyr residues by a separate activity of JAK. The
STATs dimerize, binding each other's phosphorylated
Tyr residues, and enter the nucleus, where they bind
specific regulatory regions in the DNA and alter
expression of specific genes. The products of these
genes ultimately influence feeding behavior and energy
expenditure.
|
JAK/STAT systemÀ»
±×¸²À¸·Î ¼³¸íÇÑ´Ù. (A)
JAKs = Janus
kinases
STATs = signal
transducers and
activators of
transcription
|
Signaling from activated guanylyl cyclase receptors

(a) (b)
Two types (isozymes) of guanylyl cyclase
involved in signal transduction.
(a) ANF receptor, guanylin receptor
The first type exists in two similar
membrane-spanning forms that are activated by their
extracellular ligands: ANF receptors (left) in cells
of the renal collecting ducts and the smooth muscle of
blood vessels and guanylin receptors (right) in
intestinal epitethelial cells. The guanylin receptor
is also the target of a bacterial endotoxin that
triggers severe diarrhea.
(b) NO receptor
The second type is a soluble enzyme that is
activated by intracelluar NO; this form is found in
many tissues, including smooth muscle of the heart and
blood vessels.
|
ANF = atrial
natriuretic factor
NO = nitric oxide |
Signaling from activated G protein-linked receptors

(a) cAMP pathway, involving stimulatory G protein
(Gs)
|
cAMP pathway (Gs)¸¦
±×¸²À¸·Î ¼³¸íÇÑ´Ù. (A)
cAMP

Gs = stimulatory G
protein
PKA = cAMP-dependent
protein kinase
|

(b) IP3 pathway
(Phospholipase C (PLC¥â) pathway).
Binding of a ligand to a seven transmembrane
receptor activates a G protein, which in turn
activates phospholipase C. This enzyme then cleaves
phosphatidylinositol 4,5-triphosphate (IP3) and
1,2-diacylglycerol (DAG). DAG activates protein
kinase C, which phosphorylates a series of proteins
altering cell function. The IP3 diffuses through the
cytoplasm and interacts with membrane channels in the
endoplasmic reticulum, causing release of calcium
ions and cellular responses.
|
IP3 pathway (PLC¥â)¸¦
±×¸²À¸·Î ¼³¸íÇÑ´Ù. (A)
PLC¥â
Phospholipase C¥â,
activated by G
protein
PKC Ca++-dependent
protein kinase |
Activation of glucocorticoid receptors



* Estrogen antagonist: Tamoxifen
Progesterone antagonist: RU486
|
Ç×¾ÏÁ¦ tamoxifen°ú »çÈÄ
ÇÇÀÓÁ¦ RU486ÀÇ
¾à¸®±âÀüÀ» ¼³¸íÇÑ´Ù. (A)
|
Cell Cycle and Regulation of Cell Division
<Cell Cycle and Cyclins>
: Cdk-cyclin complexes |
Cell cycleÀ» ±×¸²À¸·Î
¼³¸íÇϰí À̸¦ Á¦¾îÇÏ´Â
ÀÎÀÚµéÀ» ±â¼úÇÑ´Ù. (B) |
Growth Factors
<Classification>
1. Growth stimulators (Growth factors) |
´ëÇ¥ÀûÀÎ growth
factorµé°ú À̵éÀÇ
¿ªÇÒÀ» ±â¼úÇÑ´Ù. (B) |
= Competence factors: Rendering the cells
competent to do DNA synthesis
= Progression factors: Stimulating DNA
synthesis in competent cells |
Growth factor¿Í
oncgene°úÀÇ °ü°è ¢Ñ |
2. Growth inhibitors
: Transforming growth factor ¥â
Tumor necrosis factor
Interferon ¥â
3. Factors for cell locomotion, contractility, and differentiation
<Some Important Growth Factors>
- Epidermal growth factor (EGF)
: Proliferation of epithelial cells and fibroblasts
: EGF-EGFR tyrosine kinase (c-erb B1) ¡æ
Phosphorylation ¡æ
RNA and DNA synthesis
Transforming growth factor alpha (TGF¥á)
: Homology to EGF
- Platelet-derived growth factor (PDGF)
: Platelets (¥á granules)
Macrophages, endothelial cells, smooth muscle cells,
tumor cells
: Migration and proliferation of fibroblasts,
smooth muscles, and monocytes
: PDGF-PDGFR tyrosine kinase
- Fibroblast growth factor (FGF)
= Acidic FGF (aFGF, FGF-1)
= Basic FGF (bFGF, FGF-2): Angiogenesis
: Multifunctional
: FGF-FGFR tyrosine kinase
- Vascular endothelial growth factor (VEGF) = Vascular permeability factor
: Vasculogenesis
Angiogenesis
- Transforming growth factor beta (TGF¥â)
: Platelets, endothelial cells, lymphocytes, macrophages
: Growth inhibitor/stimulator
Fibrogenesis
Deactivation of macrophages
: Serine-threonine kinase receptor
- Cytokines - IL-1 and TNF
: Fibrosis and remodelling of connective tissue
EXTRACELLULAR MATRIX AND CELL-MATRIX INTERACTIONS
* EXTRACELLULAR MATRIX

|
Extracellular matrixÀÇ
±¸¼º¼ººÐÀ» ¿°ÅÇÑ´Ù.
(A) |

- Structural fibrous proteins
= Collagen: Strengthened organization
= Elastin: Resilience
- Adhesive glycoproteins
= Fibronectin
: Heterodimer
Mesenchymal cell-matrix attachment via integrin and RGD
= Laminin
: Heterotrimer, cross-shaped
Epithelial cell-basal lamina attachemnt
= Nonfibrillar collagen
= Thrombospondins
= Tenascin
- Polysaccharides and proteoglycans (Ground substances)
= Glycosaminoglycans (Mucopolysaccharides)
: Hyaluronic acid (hyaluronan) |
glycan
polysaccharide |
= Proteoglycans (Mucoproteins)
: Core protein + Glycosaminoglycans
- Chondroitin sulfate,
dermatan sulfate
- Heparan sulfate, heparin
- Keratan sulfate
<Organization of ECM> |
Extracellular matrixÀÇ
organizationÀ»
¿°ÅÇÑ´Ù. (A) |
- Interstitial matrix
- Basement membrane
= Type IV collagen
= Fibronectin
= Laminin
= Proteoglycans
= Others
<Cell-Matrix Interactions> |
Cell°ú Extracellular
matrixÀÇ interactionÀ»
¿°ÅÇÑ´Ù. (A) |
- Integrins
: Integrins on cell ¡ê RGD of Fibronectin, laminin, collagen in ECM,
forming focal adhesion complexes and providing tensegrity
: Cell proliferation, differentiation, locomotion
- Cell surface proteoglycans
= Syndecan ¡ê Fibronectin, collagen, thrombospondin in ECM
- Matricellular proteins
: Secreted adaptor proteins between cells and ECM
= SPARC (secreted protein acidic and rich in cysteine) (= Osteonectin)
= Osteopontin
= Thrombospondins
= Tenascin

|
Schematic illustration of the
sequence of events in the invasion
of epithelial basement membranes by
tumors (A-C). Tumor cells attach to
the basement membrane via the
laminin receptors and secrete
proteolytic enzymes, including type
IV collagenase and plasminogen
activator. Degradation of the
basement menbranes and tumor cell
migration follow. |
|